Julie Earl

3.0k total citations
50 papers, 1.0k citations indexed

About

Julie Earl is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Julie Earl has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 23 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Julie Earl's work include Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (18 papers) and Cancer Cells and Metastasis (9 papers). Julie Earl is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (18 papers) and Cancer Cells and Metastasis (9 papers). Julie Earl collaborates with scholars based in Spain, United States and Germany. Julie Earl's co-authors include Alfredo Carrato, Núria Malats, Mercedes Rodríguez-Garrote, Laura García‐Bermejo, Francisco X. Real, José Carlos Martínez Ávila, William Greenhalf, Alfonso Sanjuánbenito, Carmen Guillén‐Ponce and Eduardo Lobo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Julie Earl

44 papers receiving 1.0k citations

Peers

Countries citing papers authored by Julie Earl

Since Specialization

Citations

This map shows the geographic impact of Julie Earl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Earl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Earl more than expected).

Fields of papers citing papers by Julie Earl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Earl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Earl. The network helps show where Julie Earl may publish in the future.

Co-authorship network of co-authors of Julie Earl

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Earl. A scholar is included among the top collaborators of Julie Earl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Earl. Julie Earl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications 2025 ·Seminars in Cancer Biology ·Jörg Tost, (unknown), Daniele Campa, (unknown), (unknown), Alejandro Ibáñez‐Costa, Juan Dubrot, Julie Earl, (unknown), Agapi Kataki, (unknown), (unknown), (unknown), Ján Strnádel, Miljana Tanić, (unknown), (unknown), (unknown), (unknown), Božena Smolková	3
2	Combined analysis of a serum mRNA/miRNA marker signature and CA 19‐9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adenocarcinoma: A prospective multicenter cohort study 2024 ·United European Gastroenterology Journal ·Malte Buchholz, Ludwig Lausser, (unknown), Julie Earl, Rita T. Lawlor, Aldo Scarpa, Alfonso Sanjuánbenito, Alfredo Carrato, Núria Malats, Christine Tjaden, Nathalia A. Giese, Markus W. Büchler, Thilo Hackert, Hans A. Kestler, Thomas M. Gress	0
3	Tumor and α‐ SMA ‐expressing stromal cells in pancreatic neuroendocrine tumors have a distinct RNA profile depending on tumor grade 2024 ·Molecular Oncology ·(unknown), Raitis Pečulis, (unknown), Ilona Mandrika, (unknown), Jurijs Nazarovs, (unknown), (unknown), Julie Earl, Ignacio Ruz‐Caracuel, (unknown), Aldis Puķītis, (unknown), Vita Rovīte	2
4	Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer 2024 ·Future Science OA ·María Ángeles Vaz Salgado, Víctor Albarrán, Javier Pozas, (unknown), Vanessa Pachón, Federico Longo, Mercedes Rodríguez, (unknown), Julie Earl	0
5	Organoids, tissue slices and organotypic cultures: Advancing our understanding of pancreatic ductal adenocarcinoma through in vitro and ex vivo models 2024 ·Seminars in Cancer Biology ·Seçil Ak Aksoy, Julie Earl, Jelena Grahovac, Didem Karakaş, (unknown), (unknown), Maarten F. Bijlsma	4
6	The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer 2024 ·Familial Cancer ·Julie Earl, (unknown), Marı́a Eugenia Sánchez, Ana García García de Paredes, María Muñoz, Alfonso Sanjuánbenito, Eduardo Lobo, (unknown), (unknown), (unknown), (unknown), Ignacio Ruz‐Caracuel, (unknown), José Ramón Foruny, (unknown), Sonia Camaño, (unknown), (unknown), (unknown), Alfredo Carrato	1
7	Selection and Optimization of a Bioink Based on PANC-1- Plasma/Alginate/Methylcellulose for Pancreatic Tumour Modelling 2023 ·Polymers ·(unknown), Nieves Mateo, Laura Saldaña, (unknown), Julie Earl, Itzı́ar González, Luis M. Rodríguez‐Lorenzo	5
8	Low-intensity continuous ultrasound to inhibit cancer cell migration 2023 ·Frontiers in Cell and Developmental Biology ·Itzı́ar González, Jon Luzuriaga, (unknown), (unknown), (unknown), Jaime López, Luis Ortiz-Hernández, Luis M. Rodríguez‐Lorenzo, (unknown), José L. Blanco, Alberto A. Pinto, Julie Earl	4
9	A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications 2022 ·Journal of Visualized Experiments ·Julie Earl, Silvia Calabuig‐Fariñas, María Eugenia Sarasquete, Laura Muinelo‐Romay, Sara López‐Tarruella, Beatríz Bellosillo, Marta Rodrı́guez, (unknown), (unknown), Noelia Tarazona, Javier Hernández‐Losa, Rodrigo A. Toledo	2
10	Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study 2021 ·Cancers ·Elisa Conde, Julie Earl, (unknown), (unknown), (unknown), (unknown), José Carlos Martínez Ávila, (unknown), (unknown), (unknown), Mercedes Rodríguez-Garrote, Bruno Sáinz, Bartomeu Massutí, Pilar García‐Alfonso, Manuel Benavides, Enrique Aranda, Laura García‐Bermejo, Alfredo Carrato	11
11	Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? 2020 ·International Journal of Molecular Sciences ·Soňa Čierniková, Julie Earl, Laura García‐Bermejo, Viola Števurková, Alfredo Carrato, Božena Smolková	24
12	Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach? 2015 ·Clinical Genitourinary Cancer ·Javier Molina‐Cerrillo, Olga Martínez‐Sáez, Teresa Alonso‐Gordoa, (unknown), (unknown), Julie Earl, Enrique Grande	7
13	Additional file 2: Figure S1. of Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer 2015 ·Figshare ·Julie Earl, (unknown), José Carlos Martínez Ávila, José Montáns, Alfonso Sanjuánbenito, Mercedes Rodríguez-Garrote, (unknown), (unknown), Eduardo Lobo, Núria Malats, Alfredo Carrato, Carmen Guillén‐Ponce	2
14	New targeted approaches against the ubiquitin–proteasome system in gastrointestinal malignancies 2012 ·Expert Review of Anticancer Therapy ·Enrique Grande, Julie Earl, (unknown), Alfredo Carrato	7
15	Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors 2010 ·Proceedings of the National Academy of Sciences ·Christian Hafner, Agustí Toll, (unknown), Julie Earl, Miriam Marqués, Francesco Acquadro, Marinela Méndez‐Pertuz, Miguel Urioste, Núria Malats, Julie E. Burns, Margaret A. Knowles, Juan C. Cigudosa, Arndt Hartmann, Thomas Vogt, Michael Landthaler, Ramón M. Pujol, Francisco X. Real	63
16	Mosaic Uniparental Disomies and Aneuploidies as Large Structural Variants of the Human Genome 2010 ·The American Journal of Human Genetics ·Benjamín Rodríguez‐Santiago, Núria Malats, Nathaniel Rothman, Lluı́s Armengol, Montserrat García‐Closas, Manolis Kogevinas, Olaya Villa, Amy Hutchinson, Julie Earl, Gaëlle Marenne, Kevin B. Jacobs, Daniel Rico, Adonina Tardón, Alfredo Carrato, Gilles Thomas, Alfonso Valencia, Debra T. Silverman, Francisco X. Real, Stephen J. Chanock, Luis A. Pérez‐Jurado	76
17	Single-Nucleotide Polymorphism (SNP) Analysis to Associate Cancer Risk 2009 ·Methods in molecular biology ·Julie Earl, William Greenhalf	7
18	Development of Temporal Temperature Gradient Electrophoresis for Characterising Methanogen Diversity 2005 ·Microbial Ecology ·Julie Earl, Roger Pickup, Donald A. Ritchie, Clive Edwards	8
19	The molecular diversity of the methanogenic community in a hypereutrophic freshwater lake determined by PCR-RFLP 2004 ·Journal of Applied Microbiology ·Corinne Whitby, Julie Earl, Clare Lanyon, (unknown), Joan Robinson, (unknown), C. Edwards	8
20	Analysis of methanogen diversity in a hypereutrophic lake using PCR-RFLP analysis of mcr sequences 2003 ·Microbial Ecology ·Julie Earl, G.H. Hall, Roger Pickup, D.A. Ritchie, C. Edwards	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact